SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Xencor (XNCR) -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (44)10/29/2014 2:01:41 PM
From: scaram(o)uche  Read Replies (2) | Respond to of 136
 
Never given a FF about Amgen and RA, and still don't. ALWAYS have considered it as a potential buying op, nothing has changed in the past week other than 5871 now having a preempt.

Somehow suppressed B cells were supposed to be better than dead ones, for RA (where innovation on the T cell side continues)?? Always seemed like a stretch.

But good luck!


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News